<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <ref-type name="Journal Article">17</ref-type>
      <contributors>
        <authors>
          <author>F. Abbas</author>
          <author>F. A. Khan</author>
          <author>A. Hussain</author>
          <author>F. Ahmed</author>
          <author>M. Ahmed</author>
          <author>S. Ahmed</author>
          <author>M. Z. Ahmed</author>
          <author>M. A. Attique</author>
          <author>A. Wadood</author>
          <author>M. K. Taj.</author>
        </authors>
      </contributors>
      <titles>
        <title>PRODUCTION OF GOAT POX VIRUS VACCINE FROM A LIVE ATTENUATED GOAT POX VIRUS STRAIN</title>
        <secondary-title>Journal of Animal and Plant Sciences</secondary-title>
        <alt-title>JAPS</alt-title>
      </titles>
      <dates><year>2010</year><pub-dates><date>2010/08/01</date></pub-dates></dates>
      <volume>20</volume>
      <number>4</number>
      <pages>315-317</pages>
      <isbn>1018-7081</isbn>
      <electronic-resource-num>NA</electronic-resource-num>
      <abstract>&lt;p&gt;Kid kidney cells form less than 2 months of age were grown, 80% confluent monolayers were obtained after 10-12 days.&amp;nbsp; &amp;nbsp;Live attenuated goat pox virus vaccine (Gorgan 55, Iranian) was used to infect the confluent monolayers.&amp;nbsp; &amp;nbsp;Eighty percent cytopethic effect (CPE) was obtained on day 5 of virus inoculation.&amp;nbsp; TCID50 calculated for the pool virus was 10 5.5/ ml.&amp;nbsp; Vaccine was found free from any bacterial and mycoplasma contamination. All mice and guinea pigs were found healthy after 21days post vaccinal administration.&amp;nbsp; Vaccinated goats challenged after 14 days with 1 ml of virulent goat pox virus (TCID50 104.5/ml) did not show any unwanted reaction while controls challenged with 1 ml of virulent goat pox virus (TCID50 10 3.5/ml)&amp;nbsp; showed pox lesions and rise in body temperature. The main objective of this study was to produce and study the efficacy of this vaccine.&lt;/p&gt;</abstract>
      <keywords><keyword>attenuated, goat pox virus, confluent, monolayer, virulent, challenge</keyword></keywords>
      <publisher>Pakistan Agricultural Scientists Forum</publisher>
      <urls><related-urls><url>https://thejaps.org.pk/AbstractView.aspx?mid=2010-JAPS-411</url></related-urls></urls>
    </record>
  </records>
</xml>
